Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
| Autor: | Stephen H. Wrzesinski, Richard A. Flavell, Yisong Y. Wan |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Cancer Research
Innate immune system biology T-Lymphocytes medicine.medical_treatment Lymphokine CCL18 Dendritic Cells Lymphocyte proliferation Transforming growth factor beta Acquired immune system Killer Cells Natural Immune system Cytokine Oncology Transforming Growth Factor beta Neoplasms Immunology biology.protein medicine Animals Humans |
| Zdroj: | Clinical Cancer Research. 13:5262-5270 |
| ISSN: | 1557-3265 1078-0432 |
| DOI: | 10.1158/1078-0432.ccr-07-1157 |
| Popis: | Immune homeostasis is a delicate balance between the immune defense against foreign pathogens and suppression of the immune system to maintain self-tolerance and prevent autoimmune disease. Maintenance of this balance involves several crucial networks of cytokines and various cell types. Among these regulators, transforming growth factor-β (TGF-β) is a potent cytokine with diverse effects on hematopoietic cells. Its pivotal function within the immune system is to maintain tolerance via the regulation of lymphocyte proliferation, differentiation, and survival. In addition, TGF-β controls the initiation and resolution of inflammatory responses through the regulation of chemotaxis and activation of leukocytes in the periphery, including lymphocytes, natural killer cells, dendritic cells, macrophages, mast cells, and granulocytes. Through its pleiotropic effects on these immune cells, TGF-β prevents the development of autoimmune diseases without compromising immune responses to pathogens. However, overactivation of this pathway can lead to several immunopathologies under physiologic conditions including cancer progression, making it an attractive target for antitumor therapies. This review discusses the biological functions of TGF-β and its effects on the immune system and addresses how immunosuppression by this cytokine can promote tumorigenesis, providing the rationale for evaluating the immune-enhancing and antitumor effects of inhibiting TGF-β in cancer patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|